89 related articles for article (PubMed ID: 2312037)
1. Effects of plasma exchange (PE) in primary biliary cirrhosis (PBC). A pilot study.
Surrenti C; Pozzi M; Biagini MR; Franco C; Lombardo R; Avanzi G
Hepatogastroenterology; 1990 Feb; 37(1):128-30. PubMed ID: 2312037
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of forty patients with primary biliary cirrhosis.
Zhang F; Jia J; Cui R; Wang B; Wang H
Chin Med J (Engl); 2002 Jun; 115(6):904-8. PubMed ID: 12123563
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
[TBL] [Abstract][Full Text] [Related]
4. Intensive plasmapheresis as an alternative therapy for intractable pruritus of primary biliary cirrhosis.
Kohan AI; Findor JA; Igartua EB; Villaravid N
Transfus Sci; 1991; 12(3):197-200. PubMed ID: 10149548
[TBL] [Abstract][Full Text] [Related]
5. [Methotrexate in the therapy of primary biliary cirrhosis].
Weber P; Scheurlen M; Wiedmann KH
Dtsch Med Wochenschr; 1991 Sep; 116(36):1347-52. PubMed ID: 1884674
[TBL] [Abstract][Full Text] [Related]
6. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Angulo P; Jorgensen RA; Keach JC; Dickson ER; Smith C; Lindor KD
Hepatology; 2000 Feb; 31(2):318-23. PubMed ID: 10655252
[TBL] [Abstract][Full Text] [Related]
7. [Primary biliary cirrhosis: therapeutic trial using plasma exchange and immunosuppression. Preliminary results].
Rifle G; Mousson C; Hillon P; Marceau M; Chalopin JM; Tanter Y
Ann Med Interne (Paris); 1988; 139 Suppl 1():32-4. PubMed ID: 3247987
[TBL] [Abstract][Full Text] [Related]
8. Primary biliary cirrhosis in India.
Sarin SK; Monga R; Sandhu BS; Sharma BC; Sakhuja P; Malhotra V
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):105-9. PubMed ID: 16481294
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis.
Hempfling W; Grunhage F; Dilger K; Reichel C; Beuers U; Sauerbruch T
Hepatology; 2003 Jul; 38(1):196-202. PubMed ID: 12830002
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of primary biliary cirrhosis: a report of 45 cases].
Zhang F; Jia J; Wang B; Qian L; Yin S; Wang Y; Cui Y; You H; Ma H; Wang H; Zhang C
Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):163-7. PubMed ID: 11940315
[TBL] [Abstract][Full Text] [Related]
11. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis--an uncommon disease in Singapore.
Yap I; Wee A; Tay HH; Guan R; Kang JY
Singapore Med J; 1996 Feb; 37(1):48-50. PubMed ID: 8783913
[TBL] [Abstract][Full Text] [Related]
13. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Angulo P; Patel T; Jorgensen RA; Therneau TM; Lindor KD
Hepatology; 2000 Nov; 32(5):897-900. PubMed ID: 11050036
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome.
Hatzis GS; Fragoulis GE; Karatzaferis A; Delladetsima I; Barbatis C; Moutsopoulos HM
J Rheumatol; 2008 Oct; 35(10):2012-6. PubMed ID: 18709690
[TBL] [Abstract][Full Text] [Related]
16. Therapy of primary biliary cirrhosis with p-tolylmethylcarbinol nicotinic acid ester in combination with alpha-naphthylacetic acid.
Kaserbacher R; Propst A; Vogel W
Wien Klin Wochenschr; 1996 Nov; 108(22):722-6. PubMed ID: 8986034
[TBL] [Abstract][Full Text] [Related]
17. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
Twaddell WS; Lefkowitch J; Berk PD
Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
[TBL] [Abstract][Full Text] [Related]
18. Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis.
Mason AL; Farr GH; Xu L; Hubscher SG; Neuberger JM
Am J Gastroenterol; 2004 Dec; 99(12):2348-55. PubMed ID: 15571581
[TBL] [Abstract][Full Text] [Related]
19. Primary biliary cirrhosis: from induction to destruction.
Nishio A; Bass NM; Luketic VA; Coppel RL; Gershwin ME
Semin Gastrointest Dis; 2001 Apr; 12(2):89-102. PubMed ID: 11352123
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intra-heptic cholestasis in primary biliary cirrhosis by long term plasmapheresis.
Vankeerberghen L; Oppenheimer M; Opolon P; Lévy VG
Life Support Syst; 1983; 1 Suppl 1():106-11. PubMed ID: 6443835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
